.Pharmacolibrary.Drugs.C_CardiovascularSystem.C02C_AntiadrenergicAgentsPeripherallyActing.C02CA06_Urapidil.Urapidil .Pharmacolibrary.Drugs.C_CardiovascularSystem.C02C_AntiadrenergicAgentsPeripherallyActing.C02CA06_Urapidil.Urapidil| name: | Urapidil | |
| ATC code: | C02CA06 | route: | intravenous |
| compartments: | 2 | |
| dosage: | 25 | mg |
| volume of distribution: | 0.87 | L |
| clearance: | 7.9 | mL/min/kg |
| other parameters in model implementation | ||
Urapidil is an antihypertensive agent acting as an alpha-1 adrenergic receptor antagonist and 5-HT1A receptor agonist. It is mainly used for the treatment of acute and chronic hypertension. Urapidil is not approved by the US FDA but is used in several European countries.
Pharmacokinetic parameters of urapidil after intravenous administration in healthy adult male volunteers.